Don't Miss Out: Paradromics' Brain-Computer Interface Successfully Tested on Humans! 🤯
Competitor of Neuralink, Paradromics, successfully completes initial human brain implant procedure.
Take a peek into the cutting-edge world of neurotechnology, as Paradromics Inc., a pioneering company, has made some waves recently with their Connexus Brain-Computer Interface (BCI) platform. They've just wrapped up their first human procedure—nearly three years in the making—following a series of preclinical studies. 🩺✨
What's so special about this BCI, you ask? Well, it's all about direct communication between the brain and an external device. Dr. Matthew Willsey from the University of Michigan, alongside Dr. Oren Sagher and a multidisciplinary team of clinicians and engineers, led the game-changing surgery.
Now, imagine this: instead of your old-school keyboard, what if you could control a mouse cursor using only your thoughts? That's exactly what this implant can do! During an epilepsy resection surgery, the device was inserted to understand the impact of epilepsy on brain signaling. And guess what? It worked like a charm! This trailblazing surgery was the first step for Paradromics in pushing clinical efforts.
**NEURALINK PLAYS CHESS WITH HUMAN BRAIN CHIP IMPLANT IN NEW VIDEO! 💡✨
This isn't the only game changer in town—companies like Elon Musk's Neuralink, Synchron, and Precision Neuroscience are also racing to dominate the BCI space.
Matt Angle, CEO of Paradromics, first founded the company back in 2015, believing that a high-data-rate, high-reliability BCI could revolutionize the scope and scale of brain-health applications. The Connexus device is specifically designed to restore communication for those with severe motor impairments caused by conditions like ALS, brainstem stroke, and spinal cord injury. Thanks to AI-powered technology, the device translates brain signals into actionable outputs, allowing for natural communication at unrestricted speeds.
Paradromics is focused on making the Connexus platform a reality by conducting multiple surgeries in the coming months and undergoing the necessary regulatory approvals for clinical trials. Their ultimate goal? To delve deeper into therapeutic applications and to use this tech to help those battling neurological conditions beyond just epilepsy.
Stay tuned for more developments from Paradromics Inc. and the ever-evolving world of neurotechnology! 🚀 forget-the-mortal-coil-with-brain-chips-are-here-to-stay
Artificial intelligence is leveraged by the Connexus device developed by Paradromics to translate brain signals into actionable outputs, enabling natural communication at unprecedented speeds. The BCI technology race is heating up with companies like Neuralink, Synchron, and Precision Neuroscience also aiming to dominate the field.
